NL-OMON46384已完成2 期
eo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility - NEOCON-F
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •* Stage Ib1 cervical cancer measuring *2 - *4 cm on physical examination and imaging in any direction
- •* Histologic type: squamous cell carcinoma (SCC), adeno cell carcinoma (ACC), adeno-squamous cell carcinoma (ASC)
- •* Age *18 years and * 40 years
- •* MRI abdomen and pelvis, chest X-ray must be performed and negative for metastatic disease within 12 weeks of enrolment
- •* No metastases on pelvic lymph node dissection
排除标准
- •* Involvement of tumor in uterine corpus on MRI or hysteroscopy if performed
- •* Evidence of metastatic disease on imagining (PET/CT/MRI) performed within 12 weeks of enrolment
- •* other diagnosis of malignancy or evidence of other malignancy for 5 years before screening for this study (except non-melanoma skin cancer).
研究者
相似试验
进行中(未招募)
1 期
eo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertilitywomen =18 and = 40 years with FIGO stage Ib1 cervical carcinoma with tumor measuring = 2 cm and = 4 cm on physical examination and imagingMedDRA version: 20.0Level: HLTClassification code 10008230Term: Cervix neoplasms malignantSystem Organ Class: 100000004864EUCTR2017-003102-40-NLKI-AV120
已完成
2 期
eo-adjuvant chemotherapy, cytoreductive surgery with hypethermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin.peritoneal cancerperitoneal carcinomatosis100346521001799110017998NL-OMON38114niversitair Medisch Centrum Groningen50
进行中(未招募)
不适用
Pre treatment with chemotherapy followed by surgery and removal of all intra-abdominal tumor and intra-peritoneal heated chemotherapy for peritoneal metastastasized colorectal cancer.EUCTR2010-020787-37-NLniversitair Medisch Centrum Groningen10
进行中(未招募)
1 期
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
已完成
3 期
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
